VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
AFL
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
AFLAflac Incorporated
$121.49$61.8B
Overview & Verdict
Overview
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders
HomeStocksAFLQuarterly Financials

Aflac Incorporated (AFL) Quarterly Financials

120+ quarters historyFree accessUpdated daily

Aflac Incorporated (AFL) quarterly income statement — complete revenue, gross profit & net income history

AFL Income Statement

Income StatementBalance SheetCash FlowRatios
AnnualQuarterly
MetricQ1'26Q4'25Q3'25Q2'25Q1'25Q4'24Q3'24Q2'24Q1'24Q4'23Q3'23Q2'23Q1'23Q4'22Q3'22Q2'22Q1'22Q4'21Q3'21Q2'21
Revenue4.32B4.9B4.79B4.22B3.45B5.5B3.04B5.16B5.44B3.86B5.03B5.17B4.83B4.02B4.71B5.33B5.15B5.39B5.26B5.51B
Revenue Growth %24.96%-10.95%57.92%-18.21%-36.49%42.55%-39.69%-0.31%12.54%-4.1%6.81%-2.98%-6.16%-25.34%-10.49%-3.25%-11.16%-10.26%-6.47%2.74%
Medical Costs & Claims1.83B1.96B2.69B3.04B2.96B2.97B2.56B2.82B2.96B00000000000
Medical Cost Ratio %42.46%40.09%56.1%71.95%85.81%54.04%84.22%54.74%54.52%0%0%0%0%0%0%0%0%0%0%0%
Gross Profit2.48B2.93B2.1B1.18B490M2.53B479M2.33B2.47B3.86B5.03B5.17B4.83B4.02B4.71B5.33B5.15B5.39B5.26B5.51B
Gross Margin %57.54%59.91%43.9%28.05%14.19%45.96%15.78%45.26%45.48%100%100%100%100%100%100%100%100%100%100%100%
Gross Profit Growth %406.73%16.07%339.25%-49.31%-80.19%-34.48%-90.48%-54.88%-48.81%-4.1%6.81%-2.98%-6.16%-25.34%-10.49%-3.25%-11.16%-10.26%-6.47%2.74%
Operating Expenses1.26B1.33B110M361M345M392M387M315M303M3.57B3.23B3.35B3.49B3.5B3.38B3.62B3.85B4.16B4.15B4.14B
OpEx / Revenue %29.15%27.19%2.3%8.56%9.99%7.13%12.75%6.11%5.57%92.48%64.13%64.72%72.22%86.97%71.79%67.97%74.86%77.13%78.85%75.09%
Depreciation & Amortization0250M655M00000000000000000
Combined Ratio %71.61%67.28%58.4%80.51%95.8%61.17%96.97%60.85%60.09%92.48%64.13%64.72%72.22%86.97%71.79%67.97%74.86%77.13%78.85%75.09%
Operating Income1.23B1.6B1.99B822M145M2.13B92M2.02B2.17B290M1.8B1.82B1.34B524M1.33B1.71B1.29B1.23B1.11B1.37B
Operating Margin %28.39%32.72%41.6%19.49%4.2%38.83%3.03%39.15%39.91%7.52%35.87%35.28%27.78%13.03%28.21%32.03%25.14%22.87%21.15%24.91%
Operating Income Growth %744.83%-24.96%2067.39%-59.29%-93.32%636.21%-94.9%10.63%61.7%-44.66%35.82%6.85%3.71%-57.47%19.41%24.4%-19.28%1.23%-3.47%28.32%
EBITDA1.28B1.85B2.65B822M145M2.13B92M2.02B2.17B290M1.8B1.82B1.34B524M1.33B1.71B1.29B1.23B1.11B1.37B
EBITDA Margin %29.78%37.83%55.27%19.49%4.2%38.83%3.03%39.15%39.91%7.52%35.87%35.28%27.78%13.03%28.21%32.03%25.14%22.87%21.15%24.91%
Interest Expense60M61M57M52M50M50M50M50M47M47M49M51M48M55M59M55M56M57M57M62M
Non-Operating Income-60M0-57M00000000000000000
Pretax Income1.23B1.57B1.99B822M145M2.13B92M2.02B2.17B290M1.8B1.82B1.34B524M1.33B1.71B1.29B1.23B1.11B1.37B
Pretax Margin %28.39%32.11%41.6%19.49%4.2%38.83%3.03%39.15%39.91%7.52%35.87%35.28%27.78%13.03%28.21%32.03%25.14%22.87%21.15%24.91%
Income Tax206M193M355M223M116M233M185M264M291M22M236M191M154M339M-452M314M247M193M225M268M
Effective Tax Rate %16.82%12.28%17.8%27.13%80%10.91%201.09%13.08%13.41%7.59%13.07%10.47%11.48%64.69%-34.01%18.38%19.09%15.67%20.22%19.52%
Net Income1.02B1.38B1.64B599M29M1.9B-93M1.75B1.88B268M1.57B1.63B1.19B185M1.78B1.39B1.05B1.04B888M1.1B
Net Margin %23.62%28.17%34.2%14.2%0.84%34.59%-3.06%34.03%34.56%6.95%31.18%31.59%24.59%4.6%37.81%26.14%20.34%19.29%16.87%20.05%
Net Income Growth %3413.79%-27.5%1862.37%-65.87%-98.46%609.7%-105.93%7.41%58.16%44.86%-11.9%17.22%13.47%-82.19%100.56%26.15%-19.03%9.14%-63.84%37.27%
EPS (Diluted)1.982.593.081.110.053.42-0.173.103.250.462.642.711.930.312.822.161.581.571.321.62
EPS Growth %3635.85%-24.27%1911.76%-64.19%-98.37%643.48%-106.44%14.39%68.39%48.39%-6.38%25.46%22.15%-80.25%113.64%33.33%-15.51%13.77%-61.63%44.64%
EPS (Basic)1.992.603.091.120.053.44-0.173.113.270.462.652.721.940.322.832.171.591.581.331.63
Diluted Shares Outstanding514.78M532.01M532.01M538.42M546.88M565.01M560.41M566.84M577.48M584.88M593.6M602.93M614M622.99M631.95M643.24M652.83M662.51M671.92M680.92M